VAPORIZABLE COMPOSITIONS OF 5-MeO-DMT AND THEIR USE
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Apr 10, 2025
app pub date -
Oct 9, 2024
filing date -
Oct 9, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present application describes compositions comprising 5-MeO-DMT, one or more diluents, and optionally a cannabinoid compound for inhalation through vaporization. In certain embodiments, the compositions can be utilized as a treatment of trauma-related disorder or stressor-related disorder, such as post-traumatic stress disorder (PTSD), acute stress disorder (ASD), reactive attachment disorder (RAD), and disinhibited social engagement disorder (DSED). In particular embodiments, the composition comprises about 15-45% 5-MeO-DMT and 15-35% CBD dissolved in triethyl citrate or alpha-bisabolol, which has been observed herein to effectively remedy patients' anxiety and stress.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully